CD55 and cancer: In addition, cancer cells have evolved mechanisms to adapt to complement surveillance (i.e., by overexpression of negative regulators as CD55, CD59, CD46) or to manipulate complement response for their advantage (i.e., by removal of C5b-9 from their membranes or by the establishment of immunosuppressive milieu by regulatory immune cells recruitment).